Background The presynaptic norepinephrine transporter (NET) mediates synaptic clearance and recycling of norepinephrine. NET-deficient transgenic mice have elevated blood pressure (BP), heart rate, and catecholamine concentrations. However, the in-vivo effects of common NET variants on cardiovascular regulation at rest and during exercise are unknown.
Introduction
Genetic factors contribute substantially to interindividual variability in cardiovascular responses to exercise, stress, and drugs [1] . Variants in genes encoding adrenergic receptors and their signaling mechanisms [2] [3] [4] account for some of this variability, but other genetic determinants are unknown. The timing and extent of synaptic norepinephrine removal is determined by active clearance from the synapse by the presynaptic norepinephrine transporter (NET, SLC6A2). Genetic variations that affect this reuptake process could have profound effects on autonomic responses. Indeed, mice with deletion of NET have provided valuable insights into the potential cardiovascular consequences of altered transporter activity [5] . In these animals, NET deficiency results in higher resting blood pressure (BP), heart rate, and plasma norepinephrine and epinephrine concentrations; these differences are further accentuated by activity [5] .
Although little is known about the effect of genetic variation in NET on regulation of cardiovascular function in humans, a rare mutation (Ala457Pro), identified and studied in a single pedigree, results in a transporter with greatly reduced activity (residual activity approximately 2%) [6] . The same mutation also exhibits dominant negative effects on the expression of wild-type NET protein in transfected cells [7] . Consistent with these findings, carriers of this mutation exhibit traits of orthostatic intolerance and also have higher systolic BP (SBP) and diastolic BP (DBP), heart rate, and norepinephrine concentrations than controls [6] . Several other variants in the human NET gene (SLC6A2), such as the promoter region polymorphisms rs28386840, A-3081T, and rs2242446, T-182C, have been identified [8, 9] . The T allele of the A-3081T polymorphism drives decreased transcriptional expression of reporter constructs and is selectively transmitted to patients with attention-deficit hyperactivity disorder [8] . However, the effects of these variants on in-vivo catecholamines and catecholamine-mediated responses have not been studied.
Physical exercise is characterized by incremental sympathetic activation and concomitant parasympathetic withdrawal. Therefore, exercise is likely to accentuate functional effects of the genetic variations affecting sympathetic signal transduction [10] . Accordingly, we examined whether common polymorphisms in NET, rs28386840 [A-3081T] and rs2242446 [T-182C] , alter cardiovascular responses in healthy humans at rest and during exercise. More specifically, we examined the hypothesis that polymorphisms associated with reduced NET expression result in higher heart rate, BP, and plasma catecholamine concentrations at rest and during exercise.
Methods

Participants
This study was approved by the Institutional Review Board of the Vanderbilt University Medical Centre, Nashville, Tennessee, and all participants gave written informed consent. We studied 145 healthy participants aged 19-50 years, all of who also contributed data to a previous study [10] . All participants were nonsmokers without a history of major medical illness, without active intermittent disease or any medications or dietary supplements for at least 1 week, and received a controlled alcohol-free and caffeinefree diet (providing 150 mmol of sodium, 70 mmol of potassium, and 600 mmol of calcium daily) for 5 days before the study. Each participant reported the intensity, duration, and frequency of his/her physical activity over the last 4 weeks, and this was converted into metabolic equivalents (METS) using standard charts [11] . The exercise score for each participant was defined as the number of METS per week. They also reported their race and that of their parents and grandparents using check boxes to choose among 'Caucasian', 'African American', 'Hispanic', 'Chinese', 'Japanese', and 'other' (the latter to be specified). Multiple choices were permitted. A participant was assigned to a racial group when both parents and at least three of four grandparents were of the same race. The details of the recruitment of the participants are described elsewhere [10] .
Protocol
The exercise protocol was well standardized and previously described in detail [10, 12, 13] . In the morning (8 : 00-10 : 00 am) of the study day, participants were admitted to a temperature-controlled room (22-231C) in the Vanderbilt University Clinical Research Center after an overnight fast. A 20 G intravenous cannula was inserted into an antecubital arm vein for blood sampling. Digitized ECG signals were continuously acquired on a personal computer at 500 MHz using the Windaq Software (version 2.20, Dataq Instruments Inc., Akron, Ohio, USA). After 30 min of supine rest, participants slid to an adjacent electronically braked supine bicycle ergometer. The exercise protocol consisted of cycling at a constant rate (60 revolutions/min) at sequentially increasing workloads of 25, 50, and 75 W, for 2 min each. Average heart rate was determined from digitized ECG signals at rest and during the second minute of each of the three exercise stages. BP was measured manually at the right brachial artery and by a semiautomated oscillometric device (Dinamap MPS; GE Medical Systems, Waukesha, Wisconsin, USA) at the left brachial artery at rest and during the second minute of each of the three exercise stages using a cuff size that was appropriate for the arm circumference [14] . The mean of the manual and automated BP readings was calculated at rest and each of the three exercise stages for analysis. Blood samples for plasma catecholamines (epinephrine and norepinephrine) were collected twice, immediately before the start of exercise and then at the termination of exercise.
Genotyping
Participants were genotyped for NET polymorphisms rs28386840 (A-3081T, n = 141) and rs2242446 (T-182C, n = 140) using allelic discrimination (TaqMan) assays, performed in the Vanderbilt Center for Human Genetics Research DNA Resources Core. For each single nucleotide polymorphism, four nanograms of whole genomeamplified DNA was used as template in reactions containing 900 nmol forward and reverse amplification primers, 200 nmol of VIC and FAM dye-labeled probes, and 1X TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, California, USA). Thermal cycling (951C for 10 min, followed by 50 cycles of 921C for 15 s and 601C for 1 min) and product detection were accomplished using an ABI 7900HT Real-Time PCR System (ABI, Applied Biosystems). For quality assurance, we repeated genotyping for 20% of the samples, yielding concordant results.
Plasma catecholamine determination
Blood was collected in cooled heparin-coated tubes, which were immediately placed on ice until centrifuged at 41C for 10 min at 3000 rpm. Plasma was harvested and stored in tubes containing 40 ml of reduced glutathione (6%) at -201C until assayed. Norepinephrine and epinephrine concentrations were measured using high-performance liquid chromatography with electrochemical detection. Dihydroxybenzylamine was used as an internal standard [15] .
Data analysis, statistics, and haplotype inference
Normally distributed data are expressed as mean ± standard deviation or 95% confidence interval (CI). The effect of NET polymorphisms on cardiovascular outcomes (heart rate, SBP, and DBP), and plasma norepinephrine and epinephrine concentrations was analyzed using multiple linear regression models at rest and during the three exercise stages (25, 50 , and 75 W); all models included adjustment for potential confounders (age, sex, race, exercise score, and in addition, pre-exercise heart rate, SBP, and DBP for models that analyzed these outcomes during exercise). Increasing exercise intensity is characterized by progressive sympathetic activation and parasympathetic withdrawal; heart rate and BP at exercise are, therefore, determined by sympathetic activity to a greater degree than at rest. Thus, functional effects of genetic NET variants are expected to be increasingly pronounced with escalating exercise, and we therefore analyzed the phenotype at rest and during three incremental exercise intensities. In addition, we also modeled multiple measurements on the same patient using a measure that summarizes responses [16] . For this purpose, we used the area under the curve (AUC) of the graph plotting the parameter of interest over exercise intensity as a single summary response, reflecting data from rest and all three exercise stages. Such a summary variable is commonly used to incorporate both baseline and post intervention measures into data analysis while avoiding statistical problems associated with multiple comparisons for repeated measures [16] [17] [18] . In these analyses, the response feature was the area under the cardiovascular outcome over exercise intensity curve (AUC) for heart rate, SBP, and DBP, calculated as a summary measure of responses during exercise for each patient.
We tested for Hardy-Weinberg equilibrium using the w 2 test with 1 degree of freedom. For the analysis of outcomes, we combined patients who were homozygous for the variant NET alleles with the heterozygous patient into one group ('variant allele carriers'). All tests were two tailed, and a P value of less than 0.05 was considered significant. Analyses were carried out using the statistical software STATA v.10.0 (StataCorp, College Station, Texas, USA) and R (www.r-project.org). The R package 'Haplostats' was used to carry out haplotype inference using the expectation maximization algorithm.
Sample-size calculation
The sample size of the cohort (n = 145) was previously determined by the sample-size calculation of an earlier study [10] . SBP at maximal exercise (75 W) in that analysis was 150.5 ± 16.4 mmHg [10] . In a mixed North American population, 50% carry at least one T allele of the NET A-3081T polymorphism [8] ; therefore, we estimated that our sample size (n = 145) would provide 85% power to detect a difference of 8.2 mmHg (corresponding to 50% of the standard deviation) in SBP at maximal exercise between carriers and noncarriers of NET A-3081T (a = 0.05).
Results
Subject characteristics, genotypes, and haplotypes
We studied 145 subjects (83 European Americans and 62 African Americans; 82 women). Subject characteristics and genotyping results for NET polymorphisms are summarized in Table 1 . The mean exercise score for our patients was 14.8 ± 21.6 METS per week and did not differ between NET genotype groups (all P > 0.25). All genotypes conformed to Hardy-Weinberg equilibrium in each racial group (all P > 0.13) except for the NET A-3081T variant in African Americans (w 2 = 4.46; P = 0.03), a finding possibly attributable to genetic admixture. Minor allele frequencies were in the expected range [8] There were no significant differences in resting SBP or DBP among genotypes for the NET variants (Table 2) . However, NET variants were significantly associated with SBP response during exercise: carriers of the variant T allele of A-3081T and C allele of T-182C had higher SBP than wild-type homozygotes at all exercise stages (Tables 3  and 4 , Fig. 1 ). The summary measure, SBP-AUC, was also significantly higher in carriers of the variant alleles than in wild-type homozygotes for both NET T-182C and A-3081T (P = 0.003 and 0.009, respectively; Tables 4 and 5 ).
We also analyzed the two racial groups separately. Both NET variants were significantly associated with SBP response at all exercise intensities in European Americans (n = 83, all P < 0.01; Fig. 2 ). In African Americans, with a smaller sample size (n = 62) similar findings were only observed for the NET T-182C variant with significant differences in SBP response at 50 W (P = 0.02) and a trend in the same direction at 25 and 75 W of exercise intensity (P = 0.08 and 0.11, respectively; Fig. 2 ).
NET -3081T/-182C haplotype (haplotype 2) was associated with significantly higher SBP than NET -3081A/ -182T haplotype (haplotype 1) at all exercise intensities. SBP-AUC was also higher in -3081T/-182C than -3081A/ -182T haplotype carriers (mean adjusted difference, 466.4 mmHg W; 95% CI: 159.6-773.1; P = 0.003). When comparing SBP between haplotype 2 and 1 separately in European Americans and African Americans, the differences were significant only in the former (P = 0.03, 0.004 and 0.008 at exercise intensities of 25, 50, and 75 W, respectively, and P = 0.02 for SBP-AUC).
Diastolic blood pressure
Carriers of the variant NET -182C allele had higher DBP than wild-type homozygotes at exercise intensities of 25 W (mean adjusted difference, 3.9 mmHg; 95% CI: 1.2-6.6 mmHg; P = 0.004) and 50 W (3.8 mmHg; 95% CI: 1.0-6.6 mmHg; P = 0.008; Table 3 ). Similarly, carriers of the variant NET -3081T allele had higher DBP than wildtype homozygotes at exercise intensities of 25 W (mean adjusted difference, 2.9 mmHg; 95% CI: 0.2-5.7 mmHg; P = 0.04) and 50 W (3.0 mmHg; 95% CI: 0.2-5.9 mmHg; P = 0.04; Table 3 ). DBP-AUC was not significantly associated with either of these NET polymorphisms (all P > 0.17; Table 5 ). NET haplotypes were not associated with DBP at rest (all P > 0.44), or during exercise (all P > 0.10), or with DBP-AUC (all P > 0.26). Race-stratified haplotype analysis yielded similar negative results.
Heart rate
Resting heart rate, heart rate during exercise, and heart rate-AUC were not significantly related to NET polymorphisms (Tables 2, 3 , and 5) or NET haplotypes (all P > 0.39). Race-stratified haplotype analysis yielded similar negative results.
Catecholamine concentrations
Mean plasma norepinephrine concentrations at rest were approximately 18% lower in carriers of the variant NET -182C allele than in wild-type homozygotes (mean difference, 42.4 pg/ml; 95% CI: 9.0-75.8 pg/ml; P = 0.01; Table 2 ). Similarly, NET -3081T/-182C haplotype (haplotype 2) was associated with significantly lower restingplasma norepinephrine concentrations than the -3081A/ -182T haplotype (haplotype 1; mean difference, 39.5 pg/ml; 95% CI: 9.4-69.7 pg/ml; P = 0.01). In contrast, norepinephrine concentrations after exercise and plasma epinephrine concentrations at rest or after exercise were not associated with any of the genetic variants (Tables 2   and 3 ). Race-stratified haplotype analysis did not yield any significant results.
Discussion
This is the first study to assess the physiological effects of common NET variants on cardiovascular function at rest and during exercise. In a highly controlled setting, we found that two NET promoter polymorphisms, A-3081T and T-182C, were associated with higher SBP and DBP during exercise in healthy humans. Furthermore, haplotype analysis showed that -3081T/-182C haplotype (haplotype 2) was associated with significantly higher exercise SBP than -3081A/-182T haplotype (haplotype 1). The NET T-182C variant affected BP response to exercise in African Americans and European Americans, whereas the A-3081T variant was significant only in European Americans, in whom the two variants are in strong linkage disequilibrium. This finding suggests that the NET T-182C variant may account for the observed physiological effects, or that the variants differ in their association with BP responses in African Americans and European Americans.
The T allele of NET A-3081T polymorphism results in reduced promoter function and consequently reduced NET expression compared with the wild-type A allele [19] . The functional effects of the NET T-182C variant on gene transcription have not been assessed. At the neuropsychiatric level, the A-3081T variant has been associated with attention-deficit hyperactivity disorder and depression [8, 19] , whereas the T-182C variant has been associated with depression [19, 20] and response to antidepressant medication [21] . Reduced NET expression is expected to result in delayed clearance of norepinephrine from the noradrenergic synapses [6, 22] and, thus, increased synaptic noradrenergic activity. The enhancement of noradrenergic effects would be most significant in phases of increased sympathetic activation, such as during exercise.
In addition to delaying the clearance of synaptic norepinephrine, deficient NET activity leads to an increase in sensitivity of post-synaptic adrenergic receptors. This is shown by a marked increase in locomotor responses to sympathomimetics such as amphetamines and cocaine in NET-deficient mice and in vascular responses to sympathomimetic drugs such as a 1 -agonist phenylephrine and b-agonist isoproterenol in humans with pharmacological blockade of the NET [22, 23] . Therefore, in addition to delayed clearance of norepinephrine, enhanced postsynaptic adrenergic receptor sensitivity may contribute to exaggerated BP response to exercise in the NET variant allele carriers.
Our findings of increased BP in the carriers of variant alleles, one of which codes for a reduced-function NET, are therefore concordant with the in-vitro data and with in-vivo findings in patients with a rare genetic loss-offunction NET variant (Ala457Pro) as well as with the pharmacological inhibition of NET [6, 24] . These findings are of potential clinical relevance, as exaggerated BP response during exercise is associated with future adverse cardiovascular outcomes including hypertension [25] [26] [27] [28] .
The association of NET variants with DBP during exercise was less marked than that of SBP. During exercise, the increase in SBP is much more pronounced than that of DBP (in this study,~BP were 39.0 ± 13.5 and 14.5 ± 9.4 mmHg for SBP and DBP, respectively), reflecting a decrease in local peripheral resistance secondary to local tissue regulation in well-perfused muscle tissues [29] . Thus, SBP during exercise is a better marker of central sympathetic tone than DBP. This fact may have contributed to the weaker association between NET variants and DBP compared with SBP.
Heart rate at rest and during exercise was not associated with the NET variants. Increase in BP activates a baroreceptor-mediated vagal response that decreases heart rate [30] . It is, therefore, possible that differences in heart rate responses in carriers of NET variant alleles are countered by the baroreceptor response to a greater increase in BP in these patients. These findings suggest that exaggerated BP response in the NET variant allele carriers was driven by a greater increment in stroke volume or peripheral resistance, rather than heart rate.
Although NET mediates rapid uptake of norepinephrine at the synaptic cleft and thus directly decreases synaptic norepinephrine concentrations [31, 32] , the transporter may not have a large role in dictating resting-plasma norepinephrine or epinephrine concentrations [33] [34] [35] . Therefore, although reduction in NET function is expected to increase the synaptic norepinephrine concentration, changes in plasma norepinephrine concentrations are likely to occur only with severe reductions in NET function that allow significant spillover of synaptic norepinephrine. Indeed, loss of NET function in NET gene-targeted mice [5] , or severely decreased NET function due to a rare genetic loss-of-function polymorphism (Ala457Pro) [6] or pharmacological blockade Table 3 NET variants and cardiovascular responses and catecholamine concentrations during exercise 93.8 ± 11.7 107.6 ± 13.1 120.7 ± 14.9
55.5 ± 37.9
442.5 ± 207.0
Variant includes patients that were heterozygous or homozygous for the variant allele. BP, blood pressure. *P < 0.05. **P r 0.01. ***P r 0.001 for variant vs. wild type; all P values adjusted for age, sex, race, exercise score, fitness, and the baseline value of the outcome measure.
[24], result in increased plasma norepinephrine concentrations. However, in this study, the C allele carriers of the NET T-182C polymorphism had significantly lower resting-plasma norepinephrine concentrations. Post exercise plasma norepinephrine and resting and post exercise plasma epinephrine concentrations were not associated with this variant.
Plasma norepinephrine concentration reflects the amount of norepinephrine that is released into the synapse, the amount that spills over from the synapse, and the amount that is cleared, and therefore, is an inaccurate estimate of synaptic norepinephrine concentration [33, 34] . Thus, more specific measures of synaptic norepinephrine release such as radioisotope-based spillover studies will be required to specifically address the role of these two reduced function NET variants in regulating synaptic norepinephrine kinetics [33] .
Plasma epinephrine is mainly secreted from adrenal medulla in response to exercise and acts systemically; therefore, epinephrine concentrations are less likely affected by Regression coefficients for NET T-182C and A-3081T genotypes and other covariates, with their respective 95% confidence intervals (CI) and P values. Genotypes were coded 0 or 1 representing absence or presence of at least one NET -182 C and -3081T allele; sex and race were coded 0/1 for female/male and European American/ African American, respectively, so that regression coefficients reflect sex and racial differences. For each change of 1 unit in the covariate, the outcome (SBP or SBP-AUC) changes by the amount indicated by the respective b coefficient. Thus, for example, for each allele of NET T-182C, resting SBP increase by 1.5 mmHg (95% CI: -2.2 to 5.1; P = 0.44), SBP at maximal exercise increases by 7.4 mmHg (95% CI: 2.9-11.9 mmHg; P = 0.001), and SBP-AUC increases by 531.1 mmHg W (95% CI: 181.9-880.3 mmHg W; P = 0.003). N/A, not applicable; SBP, systolic blood pressure (reported in mmHg); SBP-AUC, systolic blood pressure-area under the curve. synaptic transporters such as NET [36, 37] . Moreover, NET is nine-fold less effective in clearing synaptic epinephrine than norepinephrine [38] and is therefore unlikely to make a major contribution to plasma epinephrine concentrations.
Our study had some limitations. It is possible that these variants could affect plasma catecholamine concentrations in presence of other genetic or environmental factors, particularly diseases associated with an increase in sympathetic activity. However, we studied healthy participants under highly controlled conditions to minimize the influence of these confounders, and thus cannot extrapolate our findings to disease states. In addition, the effects of NET polymorphisms are known to be dependent on the degree of adrenergic stimulation and physical activity [5] .
As we studied healthy participants who did not exercise to exhaustion, we might not have detected the full magnitude of functional effects of NET variants. Certainly, it will be important to study the role of these polymorphisms in other populations, such as the elderly and patients with heart failure, in which adrenergic activation is often more chronic and predicts poor outcome. Variant includes subjects that were hetero-or homozygous for the variant allele. AUC, area under the curve; BP, blood pressure; DBP, diastolic BP; HR, heart rate; SBP, systolic BP. **P < 0.01 for variant vs. the wild type; all P values adjusted for age, sex, race, fitness, and the baseline value of the outcome measure. grants P01 HL56693, GM31304, and a Pharmacogenetics Research Network Grant (U01 HL65962). Dr Stein is the recipient of the Dan May Chair in Medicine.
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